Screening PSA levels at aged 65-69 may inform the decision to continue or discontinue prostate cancer screening after age 70 years, regardless of patient race and ethnicity. The absolute risks of ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

Routine PSA testing is not recommend by the USPSTF for men 70 and older, a group expected to derive little benefit. Similar to trends in the U.S., this U.K. study found that a high number of older men ...

A prostate screening test can help to detect early signs of prostate cancer.